Torque teno virus(TTV)has been proposed as a surrogate biomarker for immune monitoring in different patient cohorts.Historically,TTV has been associated with different liver diseases such as post-transfusion hepatitis,hepatitis B,and hepatitis C,but the virus's pathogenicity is controversial.TTV is a ubiquitous DNA virus,highly prevalent and mostly indolent in the general population.Thus,TTV viral load is more relevant than prevalence to understand TTV infection.In the context of liver transplantation,TTV viral load is modulated by the immune,viral,and inflammatory status.After liver transplantation,the TTV viral load positively correlates with the intensity of immunosuppression(IS),and low TTV viral burden is a predictor of acute rejection episodes,making it an attractive marker for the efficacy of IS.However,the TTV role as a single or a panel biomarker needs to be evaluated in further independent prospective trails.